|
|
 |
|
Viewing report
|
|
|
|
GE Healthcare Medical Device Company Intelligence Report
Espicom Business Intelligence Ltd, Feb 2011, Pages: 104
GE Healthcare Medical Device Company Intelligence Report - GE Healthcare has expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery and biopharmaceutical manufacturing technologies. The company's products are designed to predict and detect disease earlier, monitor its progress and inform physicians to assist them in tailoring treatment for patients. The division manufactures, sells and services a wide range of medical equipment that helps provide a fast, non-invasive way for doctors to see broken bones, diagnose trauma cases in the emergency room, view the heart and its function, and identify early stages of cancers or brain disorders.
GE Healthcare's product portfolio includes diagnostic imaging systems such as X-ray, digital mammography, computed tomography (CT), magnetic resonance (MR) ultrasound and molecular imaging technologies. It also manufactures patient monitoring, bone densitometry, anaesthesiology and oxygen therapy, and neonatal and critical care devices. Medical diagnostics and life sciences products include diagnostic imaging agents used in medical scanning procedures, drug discovery, biopharmaceutical manufacturing and cellular technologies. The company's product services include remote diagnostic and repair services for medical equipment manufactured by GE and by others, as well as computerised data management and customer productivity services.
GE Healthcare's products and services are sold worldwide to hospitals, medical facilities, pharmaceutical and biotechnology companies, and to the life science research market.
Based in Buckinghamshire in the UK and with operations in North and South America, Europe and Asia, GE Healthcare is a business unit of GE Technology Infrastructure, an operating segment of General Electric Company (GE). The company's US headquarters are located in Waukesha (near Milwaukee) Wisconsin. GE Healthcare's products and services are sold in more than 100 countries worldwide to hospitals, medical facilities, pharmaceutical and biotechnology companies, and to the life science research market. Worldwide, GE Healthcare employs more than 46,000 people and, in 2010, generated revenues of US$16.9 billion.
In January 2011, Smiths Group rejected a US$2.45 billion offer for its largest division, Smiths Medical, from an undisclosed suitor. Smiths Group remains one of the last significant remaining conglomerates left in the UK and its Medical division has long been seen as a candidate for a spin-off or disposal. In recent times, such talk has intensified as the division has been restructured and revived, emerging as the group's largest operating subsidiary. Although the identity of the unsuccessful offer was not disclosed, media reports suggest that the approach came from Apax Partners, the UK private equity group. Other private equity groups were touted as potential bidders, but talk has also switched to rivals in the industry, including the possibility of GE Healthcare, Baxter, Covidien and Johnson & Johnson entering the fold, who may be in a position to submit higher bids.
GE is one of the largest and most diversified technology, media and financial services corporations in the world. In addition to healthcare, it has interests in the aviation; transportation; energy; home appliance and lighting; broadcasting and digital media; and consumer and business financing industries, amongst others. In 2010, the GE group generated revenues in excess of US$150 billion.
Report scope:
Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.
This company report provides:
Overview
Key contact information
Introduction to the company and its current activities
Summary of its financial performance
Who are the company's major competitors?
Key recent events in an 'at a glance' format
Financial Review
Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
Table providing in-depth five-year financial analysis
Employee data, including breakdown by company division and geographic location
Strategic Focus
Investigates the company's aims and its areas of focus
Products
Core product areas, key brands, product approvals and launches Research and Development
How much has been invested in R&D?
Where is the research based?
What alliances and agreements does the company have and with whom?
Manufacturing and Distribution
Identifying the company's manufacturing locations
Sales and marketing facilities
Agreements
With whom has the company reached agreements and what do they involve?
Key contracts awarded
Mergers, Acquisitions, Minority Investments and Divestments
Litigation
Key Corporate Events
Customers who bought this item also bought
Global Diagnostic Electrophysiology (EP) Catheters - Market Growth Analysis, 2009-2015
Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2010
Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2009
Medical Imaging Devices - A Global Market Overview
Diagnostic Electrophysiology Catheters - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
Medical Ultrasound Equipment - Global Strategic Business Report
Imaging Agents - Global Strategic Business Report
Electrophysiology (EP) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
Cardiac Monitoring And Diagnostic Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
Cardiac Medical Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
|
|
|
|
